To our knowledge, our study is the first of a kind comprehensive analysis of MMP1 and establishes a novo prognostic model based on MMP1 expression in hepatocellular carcinoma, as well as evaluating MMP1-related risk factors of immunomodulators in HCC. The gene discussed is MMP1; the disease is hepatocellular carcinoma.